VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
CRVS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
CRVSCorvus Pharmaceuticals, Inc.
$10.54$886M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksCRVSQuarterly Balance Sheet

Corvus Pharmaceuticals, Inc. (CRVS) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Corvus Pharmaceuticals, Inc. (CRVS) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

CRVS Balance Sheet

Quarterly statement

CRVS Balance Sheet

Corvus Pharmaceuticals, Inc. (CRVS) balance sheet — 12-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets202.95M220.97M239.95M58.21M66.94M75.78M45.49M54.41M42.92M48.26M22.85M27.96M33.09M37.91M35.55M43.66M51.27M58.88M64.37M71.31M
Cash & Short-Term Investments202.95M215.23M236.71M56.75M65.69M74.41M44.21M51.96M41.65M47.25M22.13M27.15M32.17M37.02M34.47M42.3M49.62M56.72M62.94M69.45M
Cash Only15.01M18.91M40.1M4.58M2.87M14.69M5M8.74M4.68M14.84M7.46M12.62M20.11M7.66M9.65M13.16M24.59M28.48M31.46M63.46M
Short-Term Investments187.93M196.32M196.61M52.17M62.82M59.72M39.21M43.22M36.97M32.41M14.67M14.53M12.06M29.36M24.81M29.14M25.03M28.25M31.48M5.99M
Accounts Receivable01.85M1.2M374K346K259K227K216K221K122K58K63K11K34K429K588K534K373K445K507K
Days Sales Outstanding--------------------
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets0575K367K318K509K569K458K548K633K240K267K220K402K136K390K339K397K986K130K900K
Total Non-Current Assets563K18.31M13.25M12.9M13.53M13.68M13.95M14.5M15.89M16.3M17.23M17.6M18.85M20.13M22.65M24.58M29.08M33.66M36.92M38.14M
Property, Plant & Equipment563K1.49M1.03M1.06M1.15M1.26M1.26M1.33M455K770K1.08M1.39M1.69M1.99M2.28M2.57M2.91M3.24M3.32M3.64M
Fixed Asset Turnover--------------------
Goodwill00000000000000000000
Intangible Assets00000000000000000000
Long-Term Investments015.11M10.5M10.99M11.53M11.79M12.06M12.54M15.19M15.4M16.07M16.12M17.07M18.02M20.23M21.88M25.91M30.18M33.37M34.27M
Other Non-Current Assets01.71M1.72M855K852K626K629K632K252K129K89K89K89K129K129K129K248K236K236K236K
Total Assets223.88M239.27M253.19M71.12M80.47M89.46M59.44M68.91M58.81M64.56M40.08M45.55M51.94M58.04M58.2M68.24M80.35M92.54M101.29M109.45M
Asset Turnover--------------------
Asset Growth %178.2%167.46%325.98%3.21%36.83%38.57%48.28%51.27%13.23%11.23%-31.12%-33.25%-35.35%-37.28%-42.54%-37.65%-32.66%-15.41%-7.27%27.97%
Total Current Liabilities15.42M13.67M12.11M9.38M8.07M8.51M9.28M35.4M46.41M13.34M6.72M6.87M7.3M7.86M8.29M10.75M13.98M10.16M9.27M9.69M
Accounts Payable04.05M4.7M2.49M1.97M3.14M1.31M2.58M1.87M1.21M1.61M1.52M1.4M2.1M1.41M1.98M4.23M2.65M2.19M1.56M
Days Payables Outstanding--11.15K7.9K----------------
Short-Term Debt493K00403K0000000001.3M001.18M000
Deferred Revenue (Current)00000000000000000000
Other Current Liabilities14.93M2.23M1.59M5.84M566K1.17M4.8M30.02M40.98M7.35M768K929K262K3.66M379K158K7.23M131K1.15M121K
Current Ratio13.16x16.16x19.81x6.21x8.29x8.91x4.90x1.54x0.92x3.62x3.40x4.07x4.53x4.82x4.29x4.06x3.67x5.80x6.95x7.36x
Quick Ratio13.16x16.16x19.81x6.21x8.29x8.91x4.90x1.54x0.92x3.62x3.40x4.07x4.53x4.82x4.29x4.06x3.67x5.80x6.95x7.36x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities139K274K406K534K632K728K834K937K0000354K700K1.04M1.37M1.69M2M2.3M2.6M
Long-Term Debt139K0406K00000000000000000
Capital Lease Obligations0274K0534K632K728K834K937K0000354K700K1.04M1.37M1.69M2M2.3M2.6M
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities00000000000000000000
Total Liabilities15.56M13.95M12.52M9.91M8.71M9.23M10.11M36.34M46.41M13.34M6.72M6.87M7.65M8.56M9.33M12.13M15.67M12.15M11.57M12.29M
Total Debt632K728K834K937K1.01M1.08M1.15M1.12M354K700K1.04M1.37M1.69M2M2.3M2.6M2.87M3.13M3.39M3.65M
Net Debt-14.38M-18.18M-39.27M-3.64M-1.86M-13.61M-3.85M-7.62M-4.33M-14.14M-6.42M-11.25M-18.41M-5.66M-7.35M-10.56M-21.72M-25.34M-28.07M-59.81M
Debt / Equity0.00x0.00x0.00x0.02x0.01x0.01x0.02x0.03x0.03x0.01x0.03x0.04x0.04x0.04x0.05x0.05x0.04x0.04x0.04x0.04x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage-11.18x--6.67x-----------------1153.50x
Total Equity208.32M225.33M240.68M61.2M71.77M80.23M49.33M32.57M12.41M51.23M33.36M38.68M44.29M49.48M48.87M56.12M64.68M80.39M89.72M97.16M
Equity Growth %190.27%180.86%387.95%87.93%478.35%56.62%47.84%-15.81%-71.98%3.52%-31.72%-31.06%-31.53%-38.44%-45.54%-42.25%-38.49%-16.61%-4.94%34.67%
Book Value per Share2.252.442.670.770.871.030.660.480.190.860.680.790.901.041.051.211.391.731.932.09
Total Shareholders' Equity208.32M225.33M240.68M61.2M71.77M80.23M49.33M32.57M12.41M51.23M33.36M38.68M44.29M49.48M48.87M56.12M64.68M80.39M89.72M97.16M
Common Stock8K8K8K7K7K7K7K7K6K6K5K5K5K5K5K5K5K5K5K5K
Retained Earnings-464.29M-443.94M-425.99M-412.29M-399.97M-389.81M-381.82M-397.01M-384.9M-344.68M-340.42M-334.72M-328.06M-322.06M-315.56M-307.69M-297.87M-283.04M-274.68M-266.38M
Treasury Stock00000000000000000000
Accumulated OCI-1.59M-1.29M-1.13M-896K-1.06M-1.15M-1.25M-1.29M-738K-1.35M-1.27M-967K-1.44M-1.37M-434K-563K-1.19M339K1.99M1.87M
Minority Interest00000000000000000000